nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—lung cancer	0.282	1	CbGaD
Posaconazole—ABCB1—Topotecan—lung cancer	0.0393	0.0864	CbGbCtD
Posaconazole—ABCB1—Gefitinib—lung cancer	0.036	0.079	CbGbCtD
Posaconazole—ABCB1—Vinorelbine—lung cancer	0.0277	0.0609	CbGbCtD
Posaconazole—CYP3A4—Topotecan—lung cancer	0.0236	0.0518	CbGbCtD
Posaconazole—ABCB1—Crizotinib—lung cancer	0.022	0.0484	CbGbCtD
Posaconazole—CYP3A4—Gefitinib—lung cancer	0.0215	0.0473	CbGbCtD
Posaconazole—ABCB1—Gemcitabine—lung cancer	0.0215	0.0473	CbGbCtD
Posaconazole—ABCB1—Erlotinib—lung cancer	0.0213	0.0467	CbGbCtD
Posaconazole—CYP3A4—Teniposide—lung cancer	0.0209	0.0459	CbGbCtD
Posaconazole—ABCB1—Paclitaxel—lung cancer	0.0195	0.0428	CbGbCtD
Posaconazole—ABCB1—Irinotecan—lung cancer	0.0192	0.0422	CbGbCtD
Posaconazole—ABCB1—Vinblastine—lung cancer	0.0171	0.0375	CbGbCtD
Posaconazole—CYP3A4—Vinorelbine—lung cancer	0.0166	0.0365	CbGbCtD
Posaconazole—ABCB1—Cisplatin—lung cancer	0.0157	0.0344	CbGbCtD
Posaconazole—ABCB1—Etoposide—lung cancer	0.0154	0.0338	CbGbCtD
Posaconazole—ABCB1—Docetaxel—lung cancer	0.0141	0.0309	CbGbCtD
Posaconazole—CYP3A4—Crizotinib—lung cancer	0.0132	0.029	CbGbCtD
Posaconazole—CYP3A4—Erlotinib—lung cancer	0.0127	0.028	CbGbCtD
Posaconazole—CYP3A4—Paclitaxel—lung cancer	0.0117	0.0256	CbGbCtD
Posaconazole—CYP3A4—Irinotecan—lung cancer	0.0115	0.0253	CbGbCtD
Posaconazole—ABCB1—Doxorubicin—lung cancer	0.0105	0.023	CbGbCtD
Posaconazole—CYP3A4—Vinblastine—lung cancer	0.0102	0.0225	CbGbCtD
Posaconazole—ABCB1—Methotrexate—lung cancer	0.0102	0.0223	CbGbCtD
Posaconazole—CYP3A4—Etoposide—lung cancer	0.00921	0.0202	CbGbCtD
Posaconazole—CYP3A4—Docetaxel—lung cancer	0.00843	0.0185	CbGbCtD
Posaconazole—CYP3A4—Doxorubicin—lung cancer	0.00628	0.0138	CbGbCtD
Posaconazole—Itraconazole—CYP2E1—lung cancer	0.000826	0.235	CrCbGaD
Posaconazole—Itraconazole—CYP1A1—lung cancer	0.000814	0.232	CrCbGaD
Posaconazole—Ketoconazole—CYP2A6—lung cancer	0.000697	0.198	CrCbGaD
Posaconazole—Ketoconazole—CYP1A1—lung cancer	0.000488	0.139	CrCbGaD
Posaconazole—Itraconazole—ABCB1—lung cancer	0.000433	0.123	CrCbGaD
Posaconazole—Ketoconazole—ABCB1—lung cancer	0.000259	0.0737	CrCbGaD
Posaconazole—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000197	0.00862	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—MCL1—lung cancer	0.000196	0.00859	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—NDRG1—lung cancer	0.000196	0.00859	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000193	0.00841	CbGpPWpGaD
Posaconazole—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000188	0.0082	CbGpPWpGaD
Posaconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000185	0.00809	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000184	0.00803	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000175	0.00765	CbGpPWpGaD
Posaconazole—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000174	0.00762	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—lung cancer	0.000173	0.00755	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000173	0.00755	CbGpPWpGaD
Posaconazole—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000168	0.00733	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.00016	0.00699	CbGpPWpGaD
Posaconazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000155	0.00677	CbGpPWpGaD
Posaconazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.00015	0.00654	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000147	0.00641	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—lung cancer	0.000146	0.00639	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000145	0.00632	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—ALDOA—lung cancer	0.000144	0.0063	CbGpPWpGaD
Posaconazole—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000144	0.00628	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000141	0.00615	CbGpPWpGaD
Posaconazole—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000136	0.00595	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—ABCG2—lung cancer	0.000136	0.00595	CbGpPWpGaD
Posaconazole—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000131	0.0057	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—TF—lung cancer	0.000127	0.00553	CbGpPWpGaD
Posaconazole—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000125	0.00547	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—ENO1—lung cancer	0.000121	0.0053	CbGpPWpGaD
Posaconazole—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.00012	0.00526	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—lung cancer	0.000119	0.00519	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000119	0.00519	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000114	0.00498	CbGpPWpGaD
Posaconazole—ABCB1—ABC-family proteins mediated transport—APOA1—lung cancer	0.000109	0.00476	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	0.000101	0.00443	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	9.34e-05	0.00408	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	8.95e-05	0.00391	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	8.9e-05	0.00389	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	8.86e-05	0.00387	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	8.51e-05	0.00372	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	8.4e-05	0.00367	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	8.4e-05	0.00367	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	8.4e-05	0.00367	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	7.78e-05	0.0034	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—TERT—lung cancer	7.27e-05	0.00318	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	7.24e-05	0.00316	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—CAT—lung cancer	7.19e-05	0.00314	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL10—lung cancer	7.15e-05	0.00312	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	7.14e-05	0.00312	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—CNDP2—lung cancer	6.98e-05	0.00305	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTM2—lung cancer	6.98e-05	0.00305	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—HIF1A—lung cancer	6.95e-05	0.00304	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	6.9e-05	0.00302	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	6.88e-05	0.00301	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—FASLG—lung cancer	6.64e-05	0.0029	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	6.53e-05	0.00285	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	6.43e-05	0.00281	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—CYP2A7—lung cancer	6.31e-05	0.00276	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	6.24e-05	0.00273	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	6.23e-05	0.00272	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	5.87e-05	0.00256	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	5.71e-05	0.00249	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	5.68e-05	0.00248	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTA3—lung cancer	5.63e-05	0.00246	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	5.55e-05	0.00242	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	5.2e-05	0.00227	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTA4—lung cancer	5.15e-05	0.00225	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	5.13e-05	0.00224	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	5.09e-05	0.00222	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	5.07e-05	0.00222	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTA2—lung cancer	5.01e-05	0.00219	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CASP8—lung cancer	4.94e-05	0.00216	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTA1—lung cancer	4.84e-05	0.00211	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	4.82e-05	0.00211	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	4.73e-05	0.00207	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	4.57e-05	0.002	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	4.57e-05	0.002	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—UGT1A1—lung cancer	4.5e-05	0.00197	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	4.44e-05	0.00194	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	4.28e-05	0.00187	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	4.22e-05	0.00184	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	4.19e-05	0.00183	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	4.15e-05	0.00181	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	3.97e-05	0.00173	CbGpPWpGaD
Posaconazole—Urinary tract disorder—Methotrexate—lung cancer	3.96e-05	0.000168	CcSEcCtD
Posaconazole—Oedema—Docetaxel—lung cancer	3.96e-05	0.000167	CcSEcCtD
Posaconazole—Weight increased—Doxorubicin—lung cancer	3.95e-05	0.000167	CcSEcCtD
Posaconazole—Pruritus—Gemcitabine—lung cancer	3.94e-05	0.000167	CcSEcCtD
Posaconazole—Urethral disorder—Methotrexate—lung cancer	3.93e-05	0.000167	CcSEcCtD
Posaconazole—Infection—Docetaxel—lung cancer	3.93e-05	0.000166	CcSEcCtD
Posaconazole—Weight decreased—Doxorubicin—lung cancer	3.93e-05	0.000166	CcSEcCtD
Posaconazole—Feeling abnormal—Etoposide—lung cancer	3.92e-05	0.000166	CcSEcCtD
Posaconazole—Hyperglycaemia—Doxorubicin—lung cancer	3.92e-05	0.000166	CcSEcCtD
Posaconazole—Diarrhoea—Irinotecan—lung cancer	3.91e-05	0.000166	CcSEcCtD
Posaconazole—ABCB1—Allograft Rejection—CXCL8—lung cancer	3.91e-05	0.00171	CbGpPWpGaD
Posaconazole—Pneumonia—Doxorubicin—lung cancer	3.89e-05	0.000165	CcSEcCtD
Posaconazole—Gastrointestinal pain—Etoposide—lung cancer	3.89e-05	0.000165	CcSEcCtD
Posaconazole—Shock—Docetaxel—lung cancer	3.89e-05	0.000165	CcSEcCtD
Posaconazole—Nervous system disorder—Docetaxel—lung cancer	3.88e-05	0.000164	CcSEcCtD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	3.88e-05	0.00169	CbGpPWpGaD
Posaconazole—Thrombocytopenia—Docetaxel—lung cancer	3.87e-05	0.000164	CcSEcCtD
Posaconazole—Infestation NOS—Doxorubicin—lung cancer	3.87e-05	0.000164	CcSEcCtD
Posaconazole—Infestation—Doxorubicin—lung cancer	3.87e-05	0.000164	CcSEcCtD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	3.87e-05	0.00169	CbGpPWpGaD
Posaconazole—Tachycardia—Docetaxel—lung cancer	3.86e-05	0.000163	CcSEcCtD
Posaconazole—Feeling abnormal—Paclitaxel—lung cancer	3.85e-05	0.000163	CcSEcCtD
Posaconazole—Skin disorder—Docetaxel—lung cancer	3.84e-05	0.000163	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.84e-05	0.000162	CcSEcCtD
Posaconazole—Hypersensitivity—Cisplatin—lung cancer	3.83e-05	0.000162	CcSEcCtD
Posaconazole—CYP3A4—Biological oxidations—HPGDS—lung cancer	3.82e-05	0.00167	CbGpPWpGaD
Posaconazole—Gastrointestinal pain—Paclitaxel—lung cancer	3.82e-05	0.000162	CcSEcCtD
Posaconazole—Diarrhoea—Gemcitabine—lung cancer	3.81e-05	0.000161	CcSEcCtD
Posaconazole—Renal failure—Doxorubicin—lung cancer	3.8e-05	0.000161	CcSEcCtD
Posaconazole—Erythema multiforme—Methotrexate—lung cancer	3.79e-05	0.000161	CcSEcCtD
Posaconazole—Neuropathy peripheral—Doxorubicin—lung cancer	3.79e-05	0.000161	CcSEcCtD
Posaconazole—Dizziness—Irinotecan—lung cancer	3.78e-05	0.00016	CcSEcCtD
Posaconazole—Urticaria—Etoposide—lung cancer	3.78e-05	0.00016	CcSEcCtD
Posaconazole—Jaundice—Doxorubicin—lung cancer	3.77e-05	0.00016	CcSEcCtD
Posaconazole—Stomatitis—Doxorubicin—lung cancer	3.77e-05	0.00016	CcSEcCtD
Posaconazole—Anorexia—Docetaxel—lung cancer	3.77e-05	0.00016	CcSEcCtD
Posaconazole—Abdominal pain—Etoposide—lung cancer	3.76e-05	0.000159	CcSEcCtD
Posaconazole—Body temperature increased—Etoposide—lung cancer	3.76e-05	0.000159	CcSEcCtD
Posaconazole—Urinary tract infection—Doxorubicin—lung cancer	3.76e-05	0.000159	CcSEcCtD
Posaconazole—Conjunctivitis—Doxorubicin—lung cancer	3.76e-05	0.000159	CcSEcCtD
Posaconazole—Eye disorder—Methotrexate—lung cancer	3.75e-05	0.000159	CcSEcCtD
Posaconazole—Tinnitus—Methotrexate—lung cancer	3.74e-05	0.000158	CcSEcCtD
Posaconazole—ABCB1—Allograft Rejection—CASP3—lung cancer	3.74e-05	0.00163	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—IL2—lung cancer	3.73e-05	0.00163	CbGpPWpGaD
Posaconazole—Asthenia—Cisplatin—lung cancer	3.73e-05	0.000158	CcSEcCtD
Posaconazole—Cardiac disorder—Methotrexate—lung cancer	3.72e-05	0.000158	CcSEcCtD
Posaconazole—CYP3A4—Biological oxidations—GSTT1—lung cancer	3.71e-05	0.00162	CbGpPWpGaD
Posaconazole—Urticaria—Paclitaxel—lung cancer	3.71e-05	0.000157	CcSEcCtD
Posaconazole—Hypotension—Docetaxel—lung cancer	3.7e-05	0.000156	CcSEcCtD
Posaconazole—Haematuria—Doxorubicin—lung cancer	3.69e-05	0.000156	CcSEcCtD
Posaconazole—Abdominal pain—Paclitaxel—lung cancer	3.69e-05	0.000156	CcSEcCtD
Posaconazole—Body temperature increased—Paclitaxel—lung cancer	3.69e-05	0.000156	CcSEcCtD
Posaconazole—CYP3A4—Biological oxidations—GCLC—lung cancer	3.67e-05	0.0016	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—CYP2A6—lung cancer	3.67e-05	0.0016	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	3.66e-05	0.0016	CbGpPWpGaD
Posaconazole—Hepatobiliary disease—Doxorubicin—lung cancer	3.66e-05	0.000155	CcSEcCtD
Posaconazole—Epistaxis—Doxorubicin—lung cancer	3.65e-05	0.000155	CcSEcCtD
Posaconazole—Angiopathy—Methotrexate—lung cancer	3.64e-05	0.000154	CcSEcCtD
Posaconazole—Vomiting—Irinotecan—lung cancer	3.64e-05	0.000154	CcSEcCtD
Posaconazole—Sinusitis—Doxorubicin—lung cancer	3.63e-05	0.000154	CcSEcCtD
Posaconazole—Immune system disorder—Methotrexate—lung cancer	3.62e-05	0.000153	CcSEcCtD
Posaconazole—Mediastinal disorder—Methotrexate—lung cancer	3.62e-05	0.000153	CcSEcCtD
Posaconazole—Agranulocytosis—Doxorubicin—lung cancer	3.61e-05	0.000153	CcSEcCtD
Posaconazole—Rash—Irinotecan—lung cancer	3.61e-05	0.000153	CcSEcCtD
Posaconazole—Dermatitis—Irinotecan—lung cancer	3.6e-05	0.000153	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Docetaxel—lung cancer	3.6e-05	0.000153	CcSEcCtD
Posaconazole—Chills—Methotrexate—lung cancer	3.6e-05	0.000152	CcSEcCtD
Posaconazole—Headache—Irinotecan—lung cancer	3.58e-05	0.000152	CcSEcCtD
Posaconazole—Insomnia—Docetaxel—lung cancer	3.58e-05	0.000151	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	3.57e-05	0.00156	CbGpPWpGaD
Posaconazole—Diarrhoea—Cisplatin—lung cancer	3.55e-05	0.00015	CcSEcCtD
Posaconazole—Paraesthesia—Docetaxel—lung cancer	3.55e-05	0.00015	CcSEcCtD
Posaconazole—Alopecia—Methotrexate—lung cancer	3.55e-05	0.00015	CcSEcCtD
Posaconazole—Vomiting—Gemcitabine—lung cancer	3.54e-05	0.00015	CcSEcCtD
Posaconazole—Bradycardia—Doxorubicin—lung cancer	3.54e-05	0.00015	CcSEcCtD
Posaconazole—Dyspnoea—Docetaxel—lung cancer	3.53e-05	0.000149	CcSEcCtD
Posaconazole—Somnolence—Docetaxel—lung cancer	3.52e-05	0.000149	CcSEcCtD
Posaconazole—Mental disorder—Methotrexate—lung cancer	3.52e-05	0.000149	CcSEcCtD
Posaconazole—Rash—Gemcitabine—lung cancer	3.51e-05	0.000149	CcSEcCtD
Posaconazole—Dermatitis—Gemcitabine—lung cancer	3.51e-05	0.000149	CcSEcCtD
Posaconazole—Hypersensitivity—Etoposide—lung cancer	3.51e-05	0.000148	CcSEcCtD
Posaconazole—Erythema—Methotrexate—lung cancer	3.49e-05	0.000148	CcSEcCtD
Posaconazole—Malnutrition—Methotrexate—lung cancer	3.49e-05	0.000148	CcSEcCtD
Posaconazole—Haemoglobin—Doxorubicin—lung cancer	3.49e-05	0.000148	CcSEcCtD
Posaconazole—Headache—Gemcitabine—lung cancer	3.49e-05	0.000148	CcSEcCtD
Posaconazole—Rhinitis—Doxorubicin—lung cancer	3.48e-05	0.000147	CcSEcCtD
Posaconazole—Dyspepsia—Docetaxel—lung cancer	3.48e-05	0.000147	CcSEcCtD
Posaconazole—Haemorrhage—Doxorubicin—lung cancer	3.47e-05	0.000147	CcSEcCtD
Posaconazole—Hepatitis—Doxorubicin—lung cancer	3.47e-05	0.000147	CcSEcCtD
Posaconazole—Hypoaesthesia—Doxorubicin—lung cancer	3.46e-05	0.000146	CcSEcCtD
Posaconazole—Pharyngitis—Doxorubicin—lung cancer	3.45e-05	0.000146	CcSEcCtD
Posaconazole—Decreased appetite—Docetaxel—lung cancer	3.44e-05	0.000146	CcSEcCtD
Posaconazole—Hypersensitivity—Paclitaxel—lung cancer	3.44e-05	0.000146	CcSEcCtD
Posaconazole—Urinary tract disorder—Doxorubicin—lung cancer	3.43e-05	0.000145	CcSEcCtD
Posaconazole—Oedema peripheral—Doxorubicin—lung cancer	3.42e-05	0.000145	CcSEcCtD
Posaconazole—Dysgeusia—Methotrexate—lung cancer	3.42e-05	0.000145	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Docetaxel—lung cancer	3.41e-05	0.000145	CcSEcCtD
Posaconazole—Asthenia—Etoposide—lung cancer	3.41e-05	0.000145	CcSEcCtD
Posaconazole—Connective tissue disorder—Doxorubicin—lung cancer	3.41e-05	0.000145	CcSEcCtD
Posaconazole—Fatigue—Docetaxel—lung cancer	3.41e-05	0.000144	CcSEcCtD
Posaconazole—Urethral disorder—Doxorubicin—lung cancer	3.41e-05	0.000144	CcSEcCtD
Posaconazole—Nausea—Irinotecan—lung cancer	3.4e-05	0.000144	CcSEcCtD
Posaconazole—Constipation—Docetaxel—lung cancer	3.38e-05	0.000143	CcSEcCtD
Posaconazole—Pain—Docetaxel—lung cancer	3.38e-05	0.000143	CcSEcCtD
Posaconazole—Back pain—Methotrexate—lung cancer	3.38e-05	0.000143	CcSEcCtD
Posaconazole—Pruritus—Etoposide—lung cancer	3.37e-05	0.000143	CcSEcCtD
Posaconazole—Asthenia—Paclitaxel—lung cancer	3.35e-05	0.000142	CcSEcCtD
Posaconazole—Nausea—Gemcitabine—lung cancer	3.31e-05	0.00014	CcSEcCtD
Posaconazole—Vomiting—Cisplatin—lung cancer	3.3e-05	0.00014	CcSEcCtD
Posaconazole—Pruritus—Paclitaxel—lung cancer	3.3e-05	0.00014	CcSEcCtD
Posaconazole—Vision blurred—Methotrexate—lung cancer	3.29e-05	0.000139	CcSEcCtD
Posaconazole—Erythema multiforme—Doxorubicin—lung cancer	3.28e-05	0.000139	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	3.28e-05	0.00143	CbGpPWpGaD
Posaconazole—Rash—Cisplatin—lung cancer	3.28e-05	0.000139	CcSEcCtD
Posaconazole—Dermatitis—Cisplatin—lung cancer	3.27e-05	0.000139	CcSEcCtD
Posaconazole—Feeling abnormal—Docetaxel—lung cancer	3.26e-05	0.000138	CcSEcCtD
Posaconazole—Diarrhoea—Etoposide—lung cancer	3.26e-05	0.000138	CcSEcCtD
Posaconazole—Eye disorder—Doxorubicin—lung cancer	3.25e-05	0.000137	CcSEcCtD
Posaconazole—Ill-defined disorder—Methotrexate—lung cancer	3.24e-05	0.000137	CcSEcCtD
Posaconazole—Tinnitus—Doxorubicin—lung cancer	3.24e-05	0.000137	CcSEcCtD
Posaconazole—Gastrointestinal pain—Docetaxel—lung cancer	3.23e-05	0.000137	CcSEcCtD
Posaconazole—Anaemia—Methotrexate—lung cancer	3.23e-05	0.000137	CcSEcCtD
Posaconazole—Cardiac disorder—Doxorubicin—lung cancer	3.22e-05	0.000137	CcSEcCtD
Posaconazole—Flushing—Doxorubicin—lung cancer	3.22e-05	0.000137	CcSEcCtD
Posaconazole—ABCB1—Metabolism—AZIN2—lung cancer	3.2e-05	0.0014	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—COL4A3BP—lung cancer	3.2e-05	0.0014	CbGpPWpGaD
Posaconazole—Diarrhoea—Paclitaxel—lung cancer	3.19e-05	0.000135	CcSEcCtD
Posaconazole—ABCB1—Allograft Rejection—VEGFA—lung cancer	3.17e-05	0.00139	CbGpPWpGaD
Posaconazole—Angiopathy—Doxorubicin—lung cancer	3.15e-05	0.000133	CcSEcCtD
Posaconazole—Malaise—Methotrexate—lung cancer	3.15e-05	0.000133	CcSEcCtD
Posaconazole—Dizziness—Etoposide—lung cancer	3.15e-05	0.000133	CcSEcCtD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	3.14e-05	0.00137	CbGpPWpGaD
Posaconazole—Immune system disorder—Doxorubicin—lung cancer	3.14e-05	0.000133	CcSEcCtD
Posaconazole—Vertigo—Methotrexate—lung cancer	3.14e-05	0.000133	CcSEcCtD
Posaconazole—Mediastinal disorder—Doxorubicin—lung cancer	3.13e-05	0.000133	CcSEcCtD
Posaconazole—Abdominal pain—Docetaxel—lung cancer	3.13e-05	0.000132	CcSEcCtD
Posaconazole—Body temperature increased—Docetaxel—lung cancer	3.13e-05	0.000132	CcSEcCtD
Posaconazole—Leukopenia—Methotrexate—lung cancer	3.13e-05	0.000132	CcSEcCtD
Posaconazole—CYP3A4—Biological oxidations—CYP2E1—lung cancer	3.12e-05	0.00136	CbGpPWpGaD
Posaconazole—Chills—Doxorubicin—lung cancer	3.12e-05	0.000132	CcSEcCtD
Posaconazole—Arrhythmia—Doxorubicin—lung cancer	3.1e-05	0.000131	CcSEcCtD
Posaconazole—Dizziness—Paclitaxel—lung cancer	3.09e-05	0.000131	CcSEcCtD
Posaconazole—Nausea—Cisplatin—lung cancer	3.09e-05	0.000131	CcSEcCtD
Posaconazole—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	3.07e-05	0.00134	CbGpPWpGaD
Posaconazole—Alopecia—Doxorubicin—lung cancer	3.07e-05	0.00013	CcSEcCtD
Posaconazole—Cough—Methotrexate—lung cancer	3.05e-05	0.000129	CcSEcCtD
Posaconazole—Mental disorder—Doxorubicin—lung cancer	3.04e-05	0.000129	CcSEcCtD
Posaconazole—Convulsion—Methotrexate—lung cancer	3.03e-05	0.000128	CcSEcCtD
Posaconazole—Vomiting—Etoposide—lung cancer	3.03e-05	0.000128	CcSEcCtD
Posaconazole—Erythema—Doxorubicin—lung cancer	3.02e-05	0.000128	CcSEcCtD
Posaconazole—Malnutrition—Doxorubicin—lung cancer	3.02e-05	0.000128	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.02e-05	0.00132	CbGpPWpGaD
Posaconazole—Rash—Etoposide—lung cancer	3e-05	0.000127	CcSEcCtD
Posaconazole—Dermatitis—Etoposide—lung cancer	3e-05	0.000127	CcSEcCtD
Posaconazole—Headache—Etoposide—lung cancer	2.98e-05	0.000126	CcSEcCtD
Posaconazole—Flatulence—Doxorubicin—lung cancer	2.98e-05	0.000126	CcSEcCtD
Posaconazole—Myalgia—Methotrexate—lung cancer	2.97e-05	0.000126	CcSEcCtD
Posaconazole—Arthralgia—Methotrexate—lung cancer	2.97e-05	0.000126	CcSEcCtD
Posaconazole—Chest pain—Methotrexate—lung cancer	2.97e-05	0.000126	CcSEcCtD
Posaconazole—Vomiting—Paclitaxel—lung cancer	2.97e-05	0.000126	CcSEcCtD
Posaconazole—Dysgeusia—Doxorubicin—lung cancer	2.96e-05	0.000125	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.95e-05	0.000125	CcSEcCtD
Posaconazole—Rash—Paclitaxel—lung cancer	2.94e-05	0.000125	CcSEcCtD
Posaconazole—Dermatitis—Paclitaxel—lung cancer	2.94e-05	0.000124	CcSEcCtD
Posaconazole—Discomfort—Methotrexate—lung cancer	2.94e-05	0.000124	CcSEcCtD
Posaconazole—Back pain—Doxorubicin—lung cancer	2.93e-05	0.000124	CcSEcCtD
Posaconazole—Headache—Paclitaxel—lung cancer	2.92e-05	0.000124	CcSEcCtD
Posaconazole—Hypersensitivity—Docetaxel—lung cancer	2.91e-05	0.000123	CcSEcCtD
Posaconazole—Muscle spasms—Doxorubicin—lung cancer	2.91e-05	0.000123	CcSEcCtD
Posaconazole—Confusional state—Methotrexate—lung cancer	2.87e-05	0.000122	CcSEcCtD
Posaconazole—Vision blurred—Doxorubicin—lung cancer	2.85e-05	0.000121	CcSEcCtD
Posaconazole—Asthenia—Docetaxel—lung cancer	2.84e-05	0.00012	CcSEcCtD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	2.84e-05	0.00124	CbGpPWpGaD
Posaconazole—Infection—Methotrexate—lung cancer	2.83e-05	0.00012	CcSEcCtD
Posaconazole—Nausea—Etoposide—lung cancer	2.83e-05	0.00012	CcSEcCtD
Posaconazole—Ill-defined disorder—Doxorubicin—lung cancer	2.81e-05	0.000119	CcSEcCtD
Posaconazole—Pruritus—Docetaxel—lung cancer	2.8e-05	0.000118	CcSEcCtD
Posaconazole—Nervous system disorder—Methotrexate—lung cancer	2.8e-05	0.000118	CcSEcCtD
Posaconazole—Anaemia—Doxorubicin—lung cancer	2.8e-05	0.000118	CcSEcCtD
Posaconazole—Thrombocytopenia—Methotrexate—lung cancer	2.79e-05	0.000118	CcSEcCtD
Posaconazole—Agitation—Doxorubicin—lung cancer	2.78e-05	0.000118	CcSEcCtD
Posaconazole—Nausea—Paclitaxel—lung cancer	2.77e-05	0.000117	CcSEcCtD
Posaconazole—Skin disorder—Methotrexate—lung cancer	2.77e-05	0.000117	CcSEcCtD
Posaconazole—Hyperhidrosis—Methotrexate—lung cancer	2.76e-05	0.000117	CcSEcCtD
Posaconazole—Malaise—Doxorubicin—lung cancer	2.73e-05	0.000115	CcSEcCtD
Posaconazole—ABCB1—Metabolism—ATP5H—lung cancer	2.72e-05	0.00119	CbGpPWpGaD
Posaconazole—Vertigo—Doxorubicin—lung cancer	2.72e-05	0.000115	CcSEcCtD
Posaconazole—Anorexia—Methotrexate—lung cancer	2.72e-05	0.000115	CcSEcCtD
Posaconazole—Syncope—Doxorubicin—lung cancer	2.71e-05	0.000115	CcSEcCtD
Posaconazole—Leukopenia—Doxorubicin—lung cancer	2.71e-05	0.000115	CcSEcCtD
Posaconazole—Diarrhoea—Docetaxel—lung cancer	2.71e-05	0.000115	CcSEcCtD
Posaconazole—Hypotension—Methotrexate—lung cancer	2.66e-05	0.000113	CcSEcCtD
Posaconazole—Loss of consciousness—Doxorubicin—lung cancer	2.66e-05	0.000113	CcSEcCtD
Posaconazole—Cough—Doxorubicin—lung cancer	2.64e-05	0.000112	CcSEcCtD
Posaconazole—Convulsion—Doxorubicin—lung cancer	2.62e-05	0.000111	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	2.62e-05	0.00114	CbGpPWpGaD
Posaconazole—Dizziness—Docetaxel—lung cancer	2.62e-05	0.000111	CcSEcCtD
Posaconazole—Hypertension—Doxorubicin—lung cancer	2.61e-05	0.000111	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Methotrexate—lung cancer	2.6e-05	0.00011	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	2.59e-05	0.00113	CbGpPWpGaD
Posaconazole—Insomnia—Methotrexate—lung cancer	2.58e-05	0.000109	CcSEcCtD
Posaconazole—Myalgia—Doxorubicin—lung cancer	2.57e-05	0.000109	CcSEcCtD
Posaconazole—Arthralgia—Doxorubicin—lung cancer	2.57e-05	0.000109	CcSEcCtD
Posaconazole—Chest pain—Doxorubicin—lung cancer	2.57e-05	0.000109	CcSEcCtD
Posaconazole—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.57e-05	0.00112	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	2.57e-05	0.00112	CbGpPWpGaD
Posaconazole—Anxiety—Doxorubicin—lung cancer	2.57e-05	0.000109	CcSEcCtD
Posaconazole—Paraesthesia—Methotrexate—lung cancer	2.56e-05	0.000108	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.56e-05	0.000108	CcSEcCtD
Posaconazole—Discomfort—Doxorubicin—lung cancer	2.54e-05	0.000108	CcSEcCtD
Posaconazole—Dyspnoea—Methotrexate—lung cancer	2.54e-05	0.000108	CcSEcCtD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.54e-05	0.00111	CbGpPWpGaD
Posaconazole—Somnolence—Methotrexate—lung cancer	2.53e-05	0.000107	CcSEcCtD
Posaconazole—Dry mouth—Doxorubicin—lung cancer	2.52e-05	0.000107	CcSEcCtD
Posaconazole—Vomiting—Docetaxel—lung cancer	2.51e-05	0.000106	CcSEcCtD
Posaconazole—Dyspepsia—Methotrexate—lung cancer	2.51e-05	0.000106	CcSEcCtD
Posaconazole—Rash—Docetaxel—lung cancer	2.49e-05	0.000106	CcSEcCtD
Posaconazole—Dermatitis—Docetaxel—lung cancer	2.49e-05	0.000105	CcSEcCtD
Posaconazole—Confusional state—Doxorubicin—lung cancer	2.49e-05	0.000105	CcSEcCtD
Posaconazole—Decreased appetite—Methotrexate—lung cancer	2.48e-05	0.000105	CcSEcCtD
Posaconazole—Headache—Docetaxel—lung cancer	2.48e-05	0.000105	CcSEcCtD
Posaconazole—Oedema—Doxorubicin—lung cancer	2.47e-05	0.000104	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Methotrexate—lung cancer	2.46e-05	0.000104	CcSEcCtD
Posaconazole—Fatigue—Methotrexate—lung cancer	2.46e-05	0.000104	CcSEcCtD
Posaconazole—Infection—Doxorubicin—lung cancer	2.45e-05	0.000104	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	2.44e-05	0.00107	CbGpPWpGaD
Posaconazole—Pain—Methotrexate—lung cancer	2.44e-05	0.000103	CcSEcCtD
Posaconazole—Shock—Doxorubicin—lung cancer	2.43e-05	0.000103	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	2.43e-05	0.00106	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PLBD1—lung cancer	2.42e-05	0.00106	CbGpPWpGaD
Posaconazole—Nervous system disorder—Doxorubicin—lung cancer	2.42e-05	0.000102	CcSEcCtD
Posaconazole—Thrombocytopenia—Doxorubicin—lung cancer	2.42e-05	0.000102	CcSEcCtD
Posaconazole—Tachycardia—Doxorubicin—lung cancer	2.41e-05	0.000102	CcSEcCtD
Posaconazole—Skin disorder—Doxorubicin—lung cancer	2.4e-05	0.000102	CcSEcCtD
Posaconazole—Hyperhidrosis—Doxorubicin—lung cancer	2.39e-05	0.000101	CcSEcCtD
Posaconazole—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.36e-05	0.00103	CbGpPWpGaD
Posaconazole—Anorexia—Doxorubicin—lung cancer	2.35e-05	9.96e-05	CcSEcCtD
Posaconazole—Nausea—Docetaxel—lung cancer	2.35e-05	9.95e-05	CcSEcCtD
Posaconazole—Feeling abnormal—Methotrexate—lung cancer	2.35e-05	9.94e-05	CcSEcCtD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	2.34e-05	0.00102	CbGpPWpGaD
Posaconazole—Gastrointestinal pain—Methotrexate—lung cancer	2.33e-05	9.87e-05	CcSEcCtD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.33e-05	0.00102	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.32e-05	0.00101	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	2.31e-05	0.00101	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	2.31e-05	0.00101	CbGpPWpGaD
Posaconazole—Hypotension—Doxorubicin—lung cancer	2.31e-05	9.76e-05	CcSEcCtD
Posaconazole—Urticaria—Methotrexate—lung cancer	2.26e-05	9.59e-05	CcSEcCtD
Posaconazole—Abdominal pain—Methotrexate—lung cancer	2.25e-05	9.54e-05	CcSEcCtD
Posaconazole—Body temperature increased—Methotrexate—lung cancer	2.25e-05	9.54e-05	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.25e-05	9.52e-05	CcSEcCtD
Posaconazole—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.24e-05	0.000979	CbGpPWpGaD
Posaconazole—Insomnia—Doxorubicin—lung cancer	2.23e-05	9.45e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—HSD17B10—lung cancer	2.22e-05	0.000969	CbGpPWpGaD
Posaconazole—Paraesthesia—Doxorubicin—lung cancer	2.22e-05	9.38e-05	CcSEcCtD
Posaconazole—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.21e-05	0.000965	CbGpPWpGaD
Posaconazole—Dyspnoea—Doxorubicin—lung cancer	2.2e-05	9.32e-05	CcSEcCtD
Posaconazole—Somnolence—Doxorubicin—lung cancer	2.19e-05	9.29e-05	CcSEcCtD
Posaconazole—Dyspepsia—Doxorubicin—lung cancer	2.17e-05	9.2e-05	CcSEcCtD
Posaconazole—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.15e-05	0.000939	CbGpPWpGaD
Posaconazole—Decreased appetite—Doxorubicin—lung cancer	2.15e-05	9.08e-05	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Doxorubicin—lung cancer	2.13e-05	9.02e-05	CcSEcCtD
Posaconazole—Fatigue—Doxorubicin—lung cancer	2.13e-05	9.01e-05	CcSEcCtD
Posaconazole—Pain—Doxorubicin—lung cancer	2.11e-05	8.94e-05	CcSEcCtD
Posaconazole—Constipation—Doxorubicin—lung cancer	2.11e-05	8.94e-05	CcSEcCtD
Posaconazole—Hypersensitivity—Methotrexate—lung cancer	2.1e-05	8.89e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.06e-05	0.000901	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CKB—lung cancer	2.06e-05	0.0009	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.06e-05	0.000898	CbGpPWpGaD
Posaconazole—Asthenia—Methotrexate—lung cancer	2.05e-05	8.66e-05	CcSEcCtD
Posaconazole—Feeling abnormal—Doxorubicin—lung cancer	2.03e-05	8.61e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.03e-05	0.000888	CbGpPWpGaD
Posaconazole—Gastrointestinal pain—Doxorubicin—lung cancer	2.02e-05	8.55e-05	CcSEcCtD
Posaconazole—Pruritus—Methotrexate—lung cancer	2.02e-05	8.54e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.99e-05	0.000869	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.97e-05	0.000861	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—AZIN2—lung cancer	1.97e-05	0.000861	CbGpPWpGaD
Posaconazole—Urticaria—Doxorubicin—lung cancer	1.96e-05	8.3e-05	CcSEcCtD
Posaconazole—Body temperature increased—Doxorubicin—lung cancer	1.95e-05	8.26e-05	CcSEcCtD
Posaconazole—Abdominal pain—Doxorubicin—lung cancer	1.95e-05	8.26e-05	CcSEcCtD
Posaconazole—Diarrhoea—Methotrexate—lung cancer	1.95e-05	8.26e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—CNDP2—lung cancer	1.94e-05	0.000847	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTM2—lung cancer	1.94e-05	0.000847	CbGpPWpGaD
Posaconazole—Dizziness—Methotrexate—lung cancer	1.89e-05	7.98e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—MTMR3—lung cancer	1.88e-05	0.000824	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.85e-05	0.000806	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PGAM1—lung cancer	1.84e-05	0.000803	CbGpPWpGaD
Posaconazole—Hypersensitivity—Doxorubicin—lung cancer	1.82e-05	7.7e-05	CcSEcCtD
Posaconazole—Vomiting—Methotrexate—lung cancer	1.81e-05	7.67e-05	CcSEcCtD
Posaconazole—Rash—Methotrexate—lung cancer	1.8e-05	7.61e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.8e-05	0.000785	CbGpPWpGaD
Posaconazole—Dermatitis—Methotrexate—lung cancer	1.8e-05	7.6e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.79e-05	0.000783	CbGpPWpGaD
Posaconazole—Headache—Methotrexate—lung cancer	1.79e-05	7.56e-05	CcSEcCtD
Posaconazole—Asthenia—Doxorubicin—lung cancer	1.77e-05	7.5e-05	CcSEcCtD
Posaconazole—ABCB1—Metabolism—CYP2A7—lung cancer	1.75e-05	0.000766	CbGpPWpGaD
Posaconazole—Pruritus—Doxorubicin—lung cancer	1.75e-05	7.39e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.74e-05	0.000759	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.73e-05	0.000758	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—SDC4—lung cancer	1.71e-05	0.000749	CbGpPWpGaD
Posaconazole—Nausea—Methotrexate—lung cancer	1.69e-05	7.17e-05	CcSEcCtD
Posaconazole—Diarrhoea—Doxorubicin—lung cancer	1.69e-05	7.15e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—ATP5H—lung cancer	1.68e-05	0.000732	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—POMC—lung cancer	1.67e-05	0.00073	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.65e-05	0.000723	CbGpPWpGaD
Posaconazole—Dizziness—Doxorubicin—lung cancer	1.63e-05	6.91e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.61e-05	0.000703	CbGpPWpGaD
Posaconazole—Vomiting—Doxorubicin—lung cancer	1.57e-05	6.64e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.57e-05	0.000684	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—RRM1—lung cancer	1.56e-05	0.000682	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTA3—lung cancer	1.56e-05	0.000682	CbGpPWpGaD
Posaconazole—Rash—Doxorubicin—lung cancer	1.56e-05	6.59e-05	CcSEcCtD
Posaconazole—Dermatitis—Doxorubicin—lung cancer	1.55e-05	6.58e-05	CcSEcCtD
Posaconazole—Headache—Doxorubicin—lung cancer	1.55e-05	6.55e-05	CcSEcCtD
Posaconazole—CYP3A4—Metabolism—PLBD1—lung cancer	1.49e-05	0.000652	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.49e-05	0.000651	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.48e-05	0.000647	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—B4GALT5—lung cancer	1.47e-05	0.000642	CbGpPWpGaD
Posaconazole—Nausea—Doxorubicin—lung cancer	1.47e-05	6.21e-05	CcSEcCtD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.44e-05	0.00063	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTA4—lung cancer	1.43e-05	0.000624	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.41e-05	0.000616	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTA2—lung cancer	1.39e-05	0.000608	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—HSD17B10—lung cancer	1.37e-05	0.000597	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTA1—lung cancer	1.34e-05	0.000587	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.33e-05	0.000582	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ABCC3—lung cancer	1.33e-05	0.00058	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—AKR1C1—lung cancer	1.29e-05	0.000562	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CKB—lung cancer	1.27e-05	0.000555	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—UGT1A1—lung cancer	1.25e-05	0.000546	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.22e-05	0.000534	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GNG11—lung cancer	1.2e-05	0.000526	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTM2—lung cancer	1.19e-05	0.000522	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CNDP2—lung cancer	1.19e-05	0.000522	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.18e-05	0.000517	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—MTMR3—lung cancer	1.16e-05	0.000507	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ALDOA—lung cancer	1.15e-05	0.000501	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.14e-05	0.000498	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PGAM1—lung cancer	1.13e-05	0.000494	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—NCOA3—lung cancer	1.11e-05	0.000486	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ADCY1—lung cancer	1.08e-05	0.000473	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ABCG2—lung cancer	1.08e-05	0.000473	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP2A7—lung cancer	1.08e-05	0.000472	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—HPGDS—lung cancer	1.06e-05	0.000464	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ENO2—lung cancer	1.06e-05	0.000464	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—SDC4—lung cancer	1.06e-05	0.000462	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PPP2R1B—lung cancer	1.05e-05	0.000461	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTT1—lung cancer	1.03e-05	0.00045	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GCLC—lung cancer	1.02e-05	0.000445	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYP2A6—lung cancer	1.02e-05	0.000445	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	9.99e-06	0.000437	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ENO1—lung cancer	9.65e-06	0.000422	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	9.64e-06	0.000421	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTA3—lung cancer	9.62e-06	0.00042	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—RRM1—lung cancer	9.62e-06	0.00042	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—B4GALT5—lung cancer	9.05e-06	0.000395	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	9.02e-06	0.000394	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTA4—lung cancer	8.8e-06	0.000385	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYP2E1—lung cancer	8.65e-06	0.000378	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTA2—lung cancer	8.58e-06	0.000375	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—NQO1—lung cancer	8.56e-06	0.000374	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTA1—lung cancer	8.27e-06	0.000362	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ABCC3—lung cancer	8.18e-06	0.000357	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	8.16e-06	0.000357	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—AKR1C1—lung cancer	7.92e-06	0.000346	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—STK11—lung cancer	7.71e-06	0.000337	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—UGT1A1—lung cancer	7.69e-06	0.000336	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GNG11—lung cancer	7.42e-06	0.000324	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTP1—lung cancer	7.14e-06	0.000312	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ALDOA—lung cancer	7.06e-06	0.000309	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CAT—lung cancer	6.94e-06	0.000303	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NCOA3—lung cancer	6.86e-06	0.0003	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ADCY1—lung cancer	6.67e-06	0.000291	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ABCG2—lung cancer	6.67e-06	0.000291	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—TYMS—lung cancer	6.63e-06	0.00029	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTM1—lung cancer	6.56e-06	0.000287	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—HPGDS—lung cancer	6.54e-06	0.000286	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ENO2—lung cancer	6.54e-06	0.000286	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PPP2R1B—lung cancer	6.5e-06	0.000284	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTT1—lung cancer	6.34e-06	0.000277	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP2A6—lung cancer	6.27e-06	0.000274	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GCLC—lung cancer	6.27e-06	0.000274	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYP1A1—lung cancer	6.22e-06	0.000272	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ERCC2—lung cancer	6.17e-06	0.000269	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ENO1—lung cancer	5.94e-06	0.00026	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—APOA1—lung cancer	5.33e-06	0.000233	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP2E1—lung cancer	5.33e-06	0.000233	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NQO1—lung cancer	5.27e-06	0.00023	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CG—lung cancer	4.87e-06	0.000213	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—STK11—lung cancer	4.75e-06	0.000208	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—POMC—lung cancer	4.64e-06	0.000203	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CREBBP—lung cancer	4.51e-06	0.000197	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTP1—lung cancer	4.4e-06	0.000192	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CD—lung cancer	4.28e-06	0.000187	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CAT—lung cancer	4.28e-06	0.000187	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ALB—lung cancer	4.23e-06	0.000185	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ABCB1—lung cancer	4.16e-06	0.000182	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—TYMS—lung cancer	4.09e-06	0.000179	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTM1—lung cancer	4.04e-06	0.000177	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP1A1—lung cancer	3.83e-06	0.000167	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ERCC2—lung cancer	3.8e-06	0.000166	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CB—lung cancer	3.73e-06	0.000163	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PTGS2—lung cancer	3.7e-06	0.000162	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—APOA1—lung cancer	3.29e-06	0.000144	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PTEN—lung cancer	3.22e-06	0.000141	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—EP300—lung cancer	3.07e-06	0.000134	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CG—lung cancer	3e-06	0.000131	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—POMC—lung cancer	2.86e-06	0.000125	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CREBBP—lung cancer	2.78e-06	0.000122	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CD—lung cancer	2.64e-06	0.000115	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ALB—lung cancer	2.6e-06	0.000114	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CB—lung cancer	2.3e-06	0.0001	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PTGS2—lung cancer	2.28e-06	9.95e-05	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CA—lung cancer	2.27e-06	9.94e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PTEN—lung cancer	1.99e-06	8.68e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—EP300—lung cancer	1.89e-06	8.28e-05	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—AKT1—lung cancer	1.86e-06	8.12e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CA—lung cancer	1.4e-06	6.12e-05	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—AKT1—lung cancer	1.14e-06	5e-05	CbGpPWpGaD
